Brett Wall served as Executive Vice President and President of the Neuroscience Portfolio at Medtronic PLC, where he led a global organization focused on developing and commercializing therapies for neurological conditions including movement disorders, chronic pain, and epilepsy. In this role, he oversaw strategic direction, R&D priorities, and commercial execution for a portfolio that includes deep brain stimulation systems, spinal cord stimulators, and other neuromodulation technologies, driving growth through innovation and expanded clinical evidence. With more than 25 years in the medical device industry, Wall previously held senior leadership positions at companies such as Boston Scientific and St. Jude Medical, where he contributed to the advancement of cardiovascular and neuromodulation products. His achievements include guiding multiple product launches that achieved significant market adoption, expanding international presence, and fostering collaborations with clinicians to improve patient outcomes in complex neurological diseases. Wall’s tenure at Medtronic emphasized operational excellence and patient-centric innovation, strengthening the company’s position in the competitive neuroscience sector before transitioning from the role. His leadership has been recognized for advancing minimally invasive solutions and integrating data-driven approaches into device development.